ARTICLE | Company News
Schwarz submits Neupro NDA, MAA
September 29, 2004 7:00 AM UTC
Schwarz (Monheim, Germany) submitted an NDA to the FDA and an MAA to the EMEA for its Neupro transdermal rotigotine patch to treat Parkinson's disease (PD). The dopamine D2 receptor agonist continuous...